Spirox is a medical device company improving the quality of life for patients suffering from nasal obstruction.
Spirox is a California-based medical device company improving the quality of life for patients suffering from nasal obstruction. They are formerly known as Nasoform. Their first product, the LATERA absorbable nasal implant is designed to address one of the most common, yet undertreated, causes of nasal obstruction today, nasal valve collapse (NVC). The company intends to use the funds to complete development, seek US marketing authorization, and initiate product commercialization. Spirox was founded in 2011 and is headquartered in Menlo Park, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 15, 2016 | Series C | $45M | 1 | Kohlberg Kravis Roberts | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Kohlberg Kravis Roberts | Yes | Series C |